Safety in Newborns

Dietary supplementation with Lactobacilli and Bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy

SUMMARY

The 454 mother/baby pairs in the randomised, double-blinded, placebo-controlled Swansea Baby Study were assessed for adverse events and the use of Lab4B probiotics was shown to be safe during pregnancy and early infancy.

Aim

The Swansea Baby study evaluated the safety of Lab4B probiotic supplementation in two potentially vulnerable populations – mothers during the last month of pregnancy and their healthy newborn babies during the first six months of life.

Method

Results

No differences were found in total adverse events either in the mums-to-be or the babies between Group 2 and Group 1.

Conclusion

This study confirms that the use of Lab4B probiotic is perfectly safe for mums-to-be and their healthy newborn babies.

Reference

Allen SJ et al 2010. Dietary supplementation with Lactobacilli and Bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy. Journal of Nutrition 140:483-488